@article{ACTR10512,
author = {Maria Aguado Sorolla and Sergio Martínez-Recio and Andrés Barba Joaquin and Mikel Portu Grivé and Margarita Majem Tarruella},
title = {Empowering treatment: insights from 35 months follow-up highlight the benefits of cemiplimab monotherapy and continued immunotherapy plus chemotherapy beyond progression in advanced non-small cell lung cancer patients with high PD-L1 expression},
journal = {AME Clinical Trials Review},
volume = {3},
number = {0},
year = {2025},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10512}
}